2023 Annual Meeting | C121 - Challenging Clinical Cases in Pediatric Neurocritical Care: Diagnosis, Management, and Prognostication

Date Tuesday 04/25/23

Time 07:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Matthew Kirschen, MD, PhD, FAAN

Topic(s) Neuro Trauma and Critical Care

Learning Objectives Participants will understand the use of integrated multimodal neurophysiologic modalities to optimize neuroprotective strategies in children with acute brain injury; understand how to use quantitative electroencephalographic features toward seizure detection, encephalopathy grading, and managing ictal-interictal continuum in critically ill children; and understand the strategic use of neuromodulatory therapy in critically ill children with a suspected neuroinflammatory disorder.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based

Event Timeline
07:00 AM - 08:00 AM EST	Speaker	Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury Brian L. Appavu, MD
07:00 AM - 08:00 AM EST	Speaker	Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury Matthew Kirschen, MD, PhD, FAAN
07:00 AM - 08:00 AM EST	Speaker	Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury Giulia Benedetti, MD
07:00 AM - 08:00 AM EST	Speaker	Is the Brain on Fire or Just Smoldering: Management of the Ictal-interictal Continuum After Acute Brain Injury France W. Fung, MD
08:00 AM - 09:00 AM EST	Speaker	Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema Matthew Kirschen, MD, PhD, FAAN
08:00 AM - 09:00 AM EST	Speaker	Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema Craig A. Press, MD, PhD
08:00 AM - 09:00 AM EST	Speaker	Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema Sona Narula, MD
08:00 AM - 09:00 AM EST	Speaker	Neuroinflammatory Disorders in the PICU: A Reversible Cause of Malignant Cerebral Edema Kristin Guilliams, MD

Faculty Disclosures
Matthew Kirschen, MD, PhD, FAAN	The institution of Dr. Kirschen has received research support from NIH.
Craig A. Press, MD, PhD	Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
Brian L. Appavu, MD	Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
Sona Narula, MD	Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Giulia Benedetti, MD	The institution of Dr. Benedetti has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Benedetti has received research support from NIH.
France W. Fung, MD	Dr. Fung has nothing to disclose.
Kristin Guilliams, MD	Dr. Guilliams has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wiseman Ashworth Law Group. The institution of Dr. Guilliams has received research support from NIH.